Analyst firms, including Cantor Fitzgerald and Morgan Stanley, raised price objectives on CVS Health shares.
4 reports, 2 independent
Updated Sep 3
Gone quiet
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst firms, including Cantor Fitzgerald and Morgan Stanley, raised price objectives on CVS Health shares.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
CVS Health
company
-
Morgan Stanley
U.S. investment bank
-
Cantor Fitzgerald
American financial services company
Related events
- Truist Financial raised its price target on CVS Health stock, with MarketBeat aggregating analyst ratings.
- Bank of America and Morgan Stanley raised price targets for Agilent Technologies stock.
- Morgan Stanley analysts hiked price targets for Salesforce.
- Analyst coverage for Vornado Realty Trust resulted in rating changes and price target adjustments from firms including Citigroup, Morgan Stanley, and Truist Financial.
- Analyst firms provided ratings and price targets for Fluence Energy, while RBC acquired new stakes in the company's stock.